08:00 , Dec 4, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Colorectal cancer Adenomatous polyposis coli (APC); BH3 interacting domain death agonist (BID) Studies in mice and patient samples suggest activating BID could help prevent colorectal...
07:00 , May 19, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Autoimmune disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Autoimmune disease Inflammatory bowel disease (IBD) BH3 interacting domain death agonist (BID); caspase recruitment domain family member 4 (CARD4; NOD1) In vitro...